Publication: Interleukin-18 induces apoptosis in human articular chondrocytes
Loading...
Date
2007
Authors
John, T. ; Kohl, B. ; Mobasheri, A. ; Ertel, W. ; Shakibaei, M.
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Elevated levels of the pro-inflammatory
cytokine, interleukin-18 (IL-18) have recently been
demonstrated in osteoarthritic cartilage. However, the
effects of IL-18 on chondrocyte signalling and matrix
biosynthesis are poorly understood. Therefore, the
present study was undertaken to further characterize the
impact of IL-18 on human articular chondrocyte in vitro.
Human articular chondrocytes were stimulated with
various concentrations of recombinant human IL-18 (1,
10, 100 ng/ml) for 0, 4, 8, 12, 24, 48, 72 h in vitro. The
effects of IL-18 on the cartilage-specific matrix protein
collagen type II, the cytoskeletal protein vinculin, the
cell matrix signal transduction receptor ß-integrin, key
signalling proteins of the MAPKinase pathway (such as
SHC (Sarc Homology Collagen) and activated
MAPKinase [ERK-1/-2]), the pro-inflammatory enzyme
cyclo-oxygenase-2 (COX-2) and the apoptosis marker
activated caspase-3 were evaluated by Western blot
analysis and immunofluorescence labelling.
Morphological features of IL-18 stimulated
chondrocytes were estimated by transmission electron
microscopy.
IL-18 lead to inhibition of collagen type IIdeposition,
decreased ß-integrin receptor and vinculin
synthesis, SHC and MAPKinase activation, increased
COX-2 synthesis and activation of caspase-3 in
chondrocytes in a time- and dose-dependent manner. Furthermore, chondrocytes treated with IL-18 exhibited
typical morphological features of apoptosis as revealed
by transmission electron microscopy.
Taken together, the results of the present study
underline key catabolic events mediated by IL-18
signalling in chondrocytes such as loss of cartilagespecific cartilagespecific
matrix and apoptosis. Inhibition of MAPKinase
signalling is hypothesized to contribute to these features.
Future therapeutics targeting IL-18 signalling pathways
may be beneficial in rheumatoid arthritis and
osteoarthritis therapy.
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Sin licencia Creative Commons.